Invemed Catalyst Fund, a New York-based private equity firm, specializes in buyouts and minority stakes in small-cap public companies.
Invemed Catalyst Fund, L.P. specializes in buyouts and minority stakes in small-cap public companies. It also sponsors corporate orphans and start-ups. The fund focuses its investments in retail, medical technology, and technology companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 1, 2009
Micell Technologies
|
Series B | $15M | Biotechnology | — |
Feb 26, 2008
Proficiency
|
Series Unknown | $4.25M | Enterprise Software | — |
Jul 12, 2007
Micell Technologies
|
Series A | $7M | Biotechnology | Yes |
Aug 5, 2004
Kalypsys
|
Series B | $29M | Biotechnology | Yes |
Oct 1, 2003
Reliant Pharmaceuticals
|
Series D | $115M | Biotechnology | Yes |
Invemed Catalyst Fund has had 1 exits. Invemed Catalyst Fund most notable exits include Reliant Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Nov 21, 2007 | Reliant Pharmaceuticals | M&A | Biotechnology | Detail |